share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

SEC ·  Oct 17 04:54

Summary by Futu AI

Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on October 15, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely monitored by investors for insights into executive confidence in the company's performance.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on October 15, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely monitored by investors for insights into executive confidence in the company's performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated